You are on page 1of 76

Medical

Applications of
Nuclear Sciences
Ilham Al-Qaradawi
Professor of Physics, Qatar University

Director, Qatar Cyclotron Research Centre, Qatar Foundation


Outline
• History of Physics discoveries
• Physics tools applied to medicine
• Medical imaging
• SPECT
• Magnetic Resonance Imaging (MRI)
• CT
• PET and PET/CT
• Hadron therapy
• Summary

WNU-SI 2010 Oxford - UK


Use of ionizing radiation for medical
applications

• Medical applications of nuclear sciences are of


particular interest as they prove many theories
wrong.
• Proof that the damaging effect of radiation has itself
been of great use.
• Proof that basic science research is not a fantasy.
• It eliminates the boundaries between the various
sciences.

WNU-SI 2010 Oxford - UK


History of “Medical” Physics discoveries

The beginnings of modern physics marks the beginning


of nuclear physics and of also of medical physics
1895 discovery of X rays 1896 Discovery of

Wilhelm Conrad Röntgen natural Radioactivity


Henri Becquerel

WNU-SI 2010 Oxford - UK


History of “Medical” Physics discoveries

J.J. Thompson 1897 1898 Discovery of Po and Ra


discovery of the electron Marie Curie & Pierre Curie

WNU-SI 2010 Oxford - UK


History of “Medical” Physics discoveries

1932 1932 – C. D. Anderson


Discovery of the neutron Discovery of the positron
James Chadwick

WNU-SI 2010 Oxford - UK


Physics tools applied to medicine:
The cyclotron

• 1930: invention of the cyclotron


• Ernest Lawrence
• 1 MeV cyclotron

WNU-SI 2010 Oxford - UK


Physics tools applied to medicine:
The Synchrotron
1945 The Synchrotron
1945: E. McMillan & V.J.Veksler
discover the principle of phase stability

1 GeV electron synchrotron


Frascati - INFN - 1959

6 GeV proton synchrotron


Bevatron - Berkeley - 1954

WNU-SI 2010 Oxford - UK


Physics tools applied to medicine:
Electron Linac

• 1947
• linac for electrons
• 4.5 MeV, 3 GHz
• William W. Hansen

WNU-SI 2010 Oxford - UK


Nuclear Magnetic Resonance (NMR)

NMR 1954
Felix Bloch and Edward Purcell

Felix Bloch
First CERN Director General
Two main areas of use

• Medical Imaging: technique of creating


images of internal human body or its
functions
• Radiation (and particle)Therapy:
Medical applications
• Diagnostic; Medical imaging (Radiology)
• X-rays and CT
• Magnetic Resonance Imaging (MRI)
• PET and PET/CT, PEM
• Treatment; Conventional radiation therapy
• Hadron therapy
• Antiproton therapy
WNU-SI 2010 Oxford - UK
Types of Medical Imaging

• Anatomical Imaging
• Functional Imaging
• Molecular Imaging

WNU-SI 2010 Oxford - UK


Anatomical Imaging

• X-ray
• MRI
• CT

WNU-SI 2010 Oxford - UK


X-ray Radiography

• Radiography involves the use of an X-


ray tube and a photographic plate.

• The patient is placed between the two


and an image is produced on the film
of the area exposed.

• A common “chest X-ray” is an


example of a radiographic X-ray.

WNU-SI 2010 Oxford - UK


Fluoroscopic x-ray imaging
• In a fluoroscopic X-ray machine the film cassette is
substituted with an imaging device (image intensifier)
which enables the radiologist to observe the part of the body
exposed live on a video monitor.

• A blocking agent, such as barium, is often swallowed by the


patient to allow the medical staff to observe internal
processes in action.

• A fluoroscopic examination can be used to locate ulcers.

WNU-SI 2010 Oxford - UK


X-ray image versus CT scan
• A conventional X-ray
image gives a shadow of
the body
• organs and tissues of
different densities show
up differently on the
radiographic film.
• Depending on where the
lamp is, you see the
outline of the pineapple or
the banana.
WNU-SI 2010 Oxford - UK
X-ray computerized tomography (CT)

COUNTS
DETECTOR

X RAYS
TUBE

A – LINEAR SAMPLING B – ANGULAR SAMPLING C - RECONSTRUCTION

This is the basic idea of


computer aided
tomography. In a CAT scan
machine, the X-ray beam
moves all around the
patient, scanning from
hundreds of different
angles. The computer
takes all this information
and puts together a 3-D
image of the body. X RAYS
COMPUTERIZED TOMOGRAPHY
Nuclear Medicine
• Radionuclides are used to determine the
extent of a medical problem in a patient.

• The radionuclide is “attached” to a


pharmaceutical, which has the properties to
deposit the radioisotope in the organ of
concern for a patient.

• External radiation detectors are used to


determine abnormalities in the organ.

• Thyroid scan and lung function tests are


examples.

WNU-SI 2010 Oxford - UK


Tracer techniques
• Different parts of the human body absorb different
elements but do not discriminate between different
isotopes.
• In tracer techniques a radioactive isotope of an element,
such as iodine, is injected into the body.
• The signals coming from the ensuing radiation then give
a picture of the size and location of the area where the
isotope was absorbed.
• Usually isotopes of a relatively short half-life, of the
order of minutes or days, are used to minimize long-term
radiation damage.
WNU-SI 2010 Oxford - UK
Medical radionuclides
• Radionuclides are used in medicine
by two general classifications:
– Nuclear Medicine for diagnostic
procedures
– Radiation Oncology for radiation
therapy.
• Nuclides used for
radiopharmaceuticals:
– should decay by emitting only photons
– Should have a short effective half-life.
– Technetium-99m and Indium-113m are
commonly used radiopharmaceuticals.
WNU-SI 2010 Oxford - UK
Functional Imaging

• Reveal structure
through function
• Image produced
depends on biological
distribution of
compound in vivo

WNU-SI 2010 Oxford - UK


Gamma Camera
• Used to record emitted internal radiation from
injected isotope to create two dimensional images.

WNU-SI 2010 Oxford - UK


Molecular Imaging

• Involves an imaging modality (MRI, ultrasound,


PET, etc.) and specially designed probes that
bind to and reveal specific biological targets
• Enables scientists and clinicians to visualize
specific biological processes non-invasively in
vivo.

WNU-SI 2010 Oxford - UK


Magnetic Resonance Imaging (MRI)

MAGNETIC FIELD: 1.5 – 3


Tesla

1H

SPIN
H2O

B B B
0 0 0

M M
M
RF
PULS MRI
E SIGNA
L

Magnetic field applied EXCITATION RELAXATION


Magnetic Resonance Imaging (MRI)

• MR image is a map of protons in water (most of


human body), with intensity determined by local
physical environment.
• Contrast and image quality are determined by
– Pulse sequence
– Field strength
– Shim quality
– Acquisition time

WNU-SI 2010 Oxford - UK


Magnetic Resonance Imaging: morphology

MRI of upper MRI of knee


torso (courtesy
NASA)

MRI of
WNU-SI 2010 Oxford - UK
shoulder
SPECT (Single photon emission computed tomography)
• Uses gamma cameras, or multi-
heads slowly rotated around the
patient.
• Able to provide true 3D
information.
• Information presented as cross-
sectional slices.
• 85% of all nuclear medicine
examinations use Mo/Tc Generators
for diagnostics of liver, lungs,
bones.
WNU-SI 2010 Oxford - UK
SPECT & PET
• 1983William Eckelman
and Richard Reba
carried out the first
successful SPECT
imaging of a
neuroreceptorin humans. Richard Reba

• 1983 Henry Wagner


carried out the first
successful PET imaging
of a neuroreceptor
Henry Wagner
WNU-SI 2010 Oxford - UK
Cyclotrons vs. Reactors

Cyclotron Reactor
charged particles neutral particles
short lived isotopes longer lived isotopes
neutron deficient nuclei neutron rich nuclei

WNU-SI 2010 Oxford - UK


Medical Isotopes

• Other isotopes can be made with cyclotron


particle accelerators

Cyclotron Target Isotopes Tracer Clinical Detector

WNU-SI 2010 Oxford - UK


Mo-99 from reactors
• Mo-99 is the most “in demand” medical isotope
• Mo-99 is shipped around (66 hrs half life)
• its “decay product” Technetium-99m is used as
tracer
• Comes “easily” from a handful of existing,
publicly funded nuclear research reactors
• Reactors are getting old

WNU-SI 2010 Oxford - UK


Crisis of 99Mo
• 30 million examinations/year rely on 99Tc
• Worldwide production of 100 000 curies per
year produced at aging nuclear reactors
– BR2 Belgium
– National Research Universal (NRU) Reactor Canada
(50%)
– OSIRIS France
– HFR Netherlands (40%)
– SAFARI-1 South Africa
• Canadian NRU off for repairs since middle of
last year
• Netherlands down for repairs
• Almost 90% of world Mo supplied by 2 closed
reactors
WNU-SI 2010 Oxford - UK
Radiochemistry

• Medical isotopes
separated under sterile
conditions
• Radiation dose to
operator must be
minimized
• Must be completed
quickly (less than one
half-life)
WNU-SI 2010 Oxford - UK
Positron Emission Tomography (PET)

Cyclotron

Radiochemistry J. Long, “The Science Creative Quarterly”,scq.ubc.ca


PET scans
• PET (positron emission tomography)
scans involve the injection into the
body of an isotope which decays by
positron emission.
• When this positron encounters an
electron they annihilate each other,
emitting two photons.
• The energy and path of these photons
leaving the body can then be used to
give an accurate picture of the area
where the isotope was absorbed.

WNU-SI 2010 Oxford - UK


PET
• When a pair of detectors detects
simultaneously one 511keV photon
each, a positron must have annihilated
on a straight line connecting those two
detectors – the so called line of response.
• The multitude of all these lines of
response is used to calculate a slice
image in a certain plane.
• produces a three-dimensional image or
picture of functional processes in the
body
WNU-SI 2010 Oxford - UK
PET Applications
• Oncology:
– Thyroid
– Sarcoma
– Lung
– Melanoma
– Lymphoma
– Head & neck
– Breast
• Neurological Applications:
• Parkinson’s, Alzheimer’s, Addiction

WNU-SI 2010 Oxford - UK


PET functional receptor imaging

Normal Subject

Parkinson’s disease

[11C] FE-CIT
Courtesy HSR MILANO
PET Isotopes
Nuclide Half-life Tracer Application

O-15 2 mins Water Cerebral blood flow

C-11 20 mins Methionine Tumour protein synthesis

N-13 10 mins Ammonia Myocardial blood flow

F-18 110 mins FDG Glucose metabolism

Ga-68 68 min DOTANOC Neuroendocrine imaging

Rb-82 72 secs Rb-82 Myocardial perfusion

WNU-SI 2010 Oxford - UK


FDG
• Most widely used PET tracer
• Glucose utilization
• Taken up avidly by most tumours
• Must be completed quickly (less than one half-
life)

WNU-SI 2010 Oxford - UK


Radiopharmacy
• To generate images, a small amount of
a radiolabeled compound (about 1-10
ng) is administered to the patient prior
to scanning
• The small amount used allows
biochemical processes to be studied
without perturbing the system (The
Tracer Principle)
• Take a medical isotope and make it
into a clinically useful compound?
• Chemistry, Chemical Biology and
Chemical Engineering
WNU-SI 2010 Oxford - UK
Instant Kits

• Instant kits provide cold, lyophilized product that


can be mixed with the isotope on site immediately
prior to delivery to the patient.

WNU-SI 2010 Oxford - UK


Mammography PET (PEM)
• Clear Crystal Collaboration (CCC) at CERN is now
working on a dedicated PET for mammography (breast
imaging), the ClearPEM.
• The aim is to be able to depict small tumors with a diameter
of 1mm to 2mm in the breast and axilla region.
• Advantages of PEM over x-ray mammography and whole
body PETs employed in hospitals at the moment are
multifold.
• Since tumor specific pharmaceuticals are used, the
probability of false diagnosis due to the presence of
inflammation, which is indiscernible from cancer on a
conventional x-ray, is reduced considerably.
PET/CT

• Combines the functional information with the


anatomical detail
• Accurate anatomical registration
• Higher diagnostic accuracy than PET or CT
alone
• CT was invented in 1972 by Godfrey Hounsfield
of EMI Laboratories

WNU-SI 2010 Oxford - UK


Pioneers

Michel Ter-Pogossian prepares a radiopharmaceutical for an examination


of Henry Wagner Jr with one of the first PET- scanners (1975)

WNU-SI 2010 Oxford - UK


Mobile PET

WNU-SI 2010 Oxford - UK


Cyclotrons used in medicine
• Baby Cyclotrons (< 18 MeV) in-house facility
• Mainly used for production of short-lived positron emitters
like 18F, 11C, 13N, 15O.
• Medium Energy Cyclotrons (< 40 MeV), centralised facility
• Majority of the cyclotron produced isotopes are produced
using such machine viz, 123I, 201Tl, 67Ga, 68Ga, 103Pd etc.
• High Energy Cyclotrons (above 40 MeV), centralised
facilities and research institutions
• Used for production of few radioisotopes requiring high
energy for production viz, 67Cu, 82Sr, 211At…
WNU-SI 2010 Oxford - UK
Accelerators for all stages

• Isotope production
• In diagnostics
• and endotherapy

WNU-SI 2010 Oxford - UK


Types of Accelerators

• Cyclotrons
• Syncrotrons
• Linacs

WNU-SI 2010 Oxford - UK


Three classes of medical accelerators

Electron linacs for conventional radiation therapy, including advanced


modalities:
•Cyberknife
•IntraOperative RT (IORT)
•Intensity Modulated RT

Low-energy cyclotrons for production


of radionuclides for medical diagnostics

Medium-energy cyclotrons and


synchrotrons for hadron therapy with
protons (250 MeV) or light ion
beams (400 MeV/u 12C-ions)
WNU-SI 2010 Oxford - UK
Baby Cyclotrons
• Accelerated protons

WNU-SI 2010 Oxford - UK


Medium energy cyclotrons

WNU-SI 2010 Oxford - UK


High-energy cyclotrons
• IBA‟s ARRONAX in
Nantes
• 4 Particles: H- / D- / He2+/
HH+
• Variable energy: 15 MeV
70 MeV

WNU-SI 2010 Oxford - UK


Medical accelerators: electron linac

Varian Clinac 1800 installed


in the S. Anna Hospital in
Como (Italy)

WNU-SI 2010 Oxford - UK


CyberKnife (CK) Robotic Surgery System

6 MV Linac mounted on a robotic arm

• The CyberKnife system is a


method of delivering
radiotherapy, with the
intention of targeting
treatment more accurately
than standard radiotherapy.
http://www.accuray.com/Products/Cyberknife/index.aspx
Radiation therapy

• Radiation is used to destroy tumors present in a


body. Damage to healthy cells is controlled by
using radioactive samples with specific half-lives
which subsequently are intended to decay in the
vicinity of the tumor when injected into the body.

WNU-SI 2010 Oxford - UK


Radiation oncology
• Radiation Oncology (study/treatment of tumors) uses
radionuclides for tumor treatment.

• Cobalt-60 is generally used for the high activity sealed


source.

• This consists of a mechanical device, which moves the


source to an opening in a collimator which projects a beam
of photons used for treatment.

WNU-SI 2010 Oxford - UK


Intensity Modulated Radiation Therapy
(IMRT)
• IMRT: advanced mode of high-precision radiotherapy utilizing
computer-controlled linac to deliver precise radiation doses to a
malignant tumor or specific areas within the tumor.
• Allows for the radiation dose to conform to the 3D shape of tumor.
• Allows higher radiation doses to be focused to tumor regions while
minimizing the dose to surrounding normal critical structures.
• Treatment planned by 3-D CT images of the patient in conjunction
with computerized dose calculations to conform to the tumor shape.
• The ratio of normal tissue dose to tumor dose is reduced to a
minimum, hence, higher and more effective radiation doses can safely
be delivered to tumors with fewer side effects

WNU-SI 2010 Oxford - UK


Intensity Modulated Radiation Therapy

An example of intensity
modulated treatment
planning with photons.
Through the addition of
9 fields it is possible to
construct a highly
conformal dose
distribution with good
dose sparing in the
region of the brain stem
(courtesy of T. Lomax,
PSI).

WNU-SI 2010 Oxford - UK E. Pedroni, Europhysics News (2000) Vol. 31 No. 6


Hadron therapy: n, p and C-ion beams

Charged hadrons have a much better energy deposition with respect to X-rays

“hadrons” are
made of quarks

WNU-SI 2010 Oxford - UK


Cancer therapy with photons, electrons
and hadron beams
• Linear accelerators
• In the world radiation
oncologists use 15000
electron linacs
• 40% of all the existing
accelerators.
• Beams of protons to
deliver more targeted,
precise doses
WNU-SI 2010 Oxford - UK
Protons and ions spare healthy
tissues
• Unlike photons or electrons,
proton beams deposit most of
their energy at the end of their
paths in the so-called Bragg
peak. Hence, targeting deep-
seated tumours, close to sensitive
organs, with much reduced risk
to surrounding healthy tissue.
• benefit of proton and heavy-ion
therapy is that the beams can be
"tuned" to deliver a high dose of
energy at a precise location

WNU-SI 2010 Oxford - UK


Proton therapy: cyclotrons and
synchrotrons
• Proton therapy is booming

WNU-SI 2010 Oxford - UK


Therapy with carbon ions
• Carbon allows extremely precise targeting of the
tumour.
• lighter particles such as protons, whilst
depositing their energy in the Bragg peak, cause
far fewer double-strand breaks than heavier
ones like carbon.
• Tumours eligible for carbon ion radiotherapy so
far are: skull base tumours and tumours close to
the spinal chord.
WNU-SI 2010 Oxford - UK
HIMAC in Chiba, Japan is the pioneer of
carbon therapy
• Japan has pioneered the use of carbon ions in the treatment of
tumours, treating the first patient in 1994.
• A new facility has come on line and others are under construction.
• HIMAC was the world's first heavy-ion accelerator facility
dedicated to medical use.

(Prof. H. Tsujii)

WNU-SI 2010 Oxford - UK


Germany: the GSI pilot project
• 1998-2009
• The GSI facility will be used for a
pilot project to treat several
hundred patients over a five-year
period.
• A typical course of treatment
involves around 20 half-hour
sessions on 20 consecutive days.
• The GSI facility is the first to
provide extremely precise tumor
conformity using magnetic beam
scanning in two dimensions

WNU-SI 2010 Oxford - UK http://cerncourier.com/cws/article/cern/27920


Future Facilities
• GSI Pioneer work (with HIMAC) in carbon-therapy
• CNAO, Pavia, Carbon Facility.
• Building Accelerator based on the PIMMS design
(CERN)
• ETOILE Carbon-Therapy facility, Lyon, France
• Heidelberg Ion Therapy, Germany.

WNU-SI 2010 Oxford - UK


The Hyogo “dual” Centre
• End of 2008
• protons: 2000 patients
• carbon ions: 500 patients

WNU-SI 2010 Oxford - UK


Heidelberg Ion Therapy

WNU-SI 2010 Oxford - UK


PIMMS (Proton Ion Medical Machine
Study) at CERN from 1996 to 2000
• Ugo Amaldi drew the interest of the
CERN management to the design of
an ion synchrotron optimized for
such a medical application
• CNAO, Pavia, Carbon Facility is
building accelerator based on the
PIMMS design (CERN).

WNU-SI 2010 Oxford - UK


Therapy is Commercialized

• Electron, proton and heavy ion accelerators for


radiotherapy and hadron therapy are now built (and
operated) by industry.
• Several companies have demonstrated that they can
built very performing accelerator turnkey facilities
with medical assurance quality standards for the
best price.

WNU-SI 2010 Oxford - UK


Antiproton Cancer Therapy
• Researchers at CERN have found that the antiproton, can effectively
treat cancer.
• Antiprotons strip electrons off atoms in the cells, causing ionization
and killing the cell they are in.
• A proton beam could also be used for ionization but when antiproton
beam eventually come to a stop at the focus, the annihilation of both
particles will release a huge amount of energy (in the context of a
single cell)....which is much more effective at killing selected cells
than simple ionization.
• Scientists estimate that routine clinical application of matter-
antimatter annihilation to cancer treatment should be a reality in 10-15
years.
WNU-SI 2010 Oxford - UK
Conclusions
• Medical applications are Multi-disciplinary; can only be
developed by collaboration between academic and medical
Research, industrial Development and Commercialization.
• New isotope production and separation techniques are
needed to provide a steady supply of medical isotopes.
• Accelerators may solve the technetium crisis.
• Automation, robotics, and technology are necessary aspect.
• Molecular imaging is enhancing health care by providing
early detection and better treatment of tumors with less side
effects on healthy tissue.
WNU-SI 2010 Oxford - UK
Takeaway points
• The progress in the field of radiation applications is not only driven by
advancement of nuclear and radiation physics but also by the
development of technology, to what extent is this valid?
• Better planning, research and cooperation worldwide are required to
avoid future radioisotope production crisis such as Mo-99.
• What seemed to be pure or basic science research in the past have had a
lot of impact on applications of medical imaging.
• Research is required to find techniques to reduce the damaging effects on
healthy cells and target diseased cells more effectively.
• Do scientists really need to use antimatter for cancer treatment? Bearing
in mind that it is the most expensive substance on earth; in 1999 the
estimated cost for 1g of antimatter was about $62.5b, and is very rare;
only 9 nanograms of antimatter are produced so far in all labs.
WNU-SI 2010 Oxford - UK
Questions?
Thank you for your attention

ilham@qu.edu.qa
WNU-SI 2010 Oxford - UK

You might also like